SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029612
Filing Date
2018-11-14
Accepted
2018-11-14 17:18:10
Documents
44
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gnpx-10q_20180930.htm 10-Q 966984
2 EX-31.1 gnpx-ex311_8.htm EX-31.1 16205
3 EX-31.2 gnpx-ex312_7.htm EX-31.2 17718
4 EX-32.1 gnpx-ex321_9.htm EX-32.1 8450
  Complete submission text file 0001564590-18-029612.txt   3226617

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnpx-20180930.xml EX-101.INS 386815
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20180930.xsd EX-101.SCH 37140
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20180930_cal.xml EX-101.CAL 23120
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20180930_def.xml EX-101.DEF 115863
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20180930_lab.xml EX-101.LAB 281918
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20180930_pre.xml EX-101.PRE 202727
Mailing Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712
Business Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712 512-708-0155
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 181185126
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1